PICODRALAZINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C14H13N5
Molecular Weight	251.2865
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of PICODRALAZINE

Structure Search

SMILES

NNC1=NN=C(CC2=CC=NC=C2)C3=CC=CC=C13

InChI

InChIKey=KCASCYQNVLPVDP-UHFFFAOYSA-N

InChI=1S/C14H13N5/c15-17-14-12-4-2-1-3-11(12)13(18-19-14)9-10-5-7-16-8-6-10/h1-8H,9,15H2,(H,17,19)

HIDE SMILES / InChI

Molecular Formula	C14H13N5
Molecular Weight	251.2865
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://books.google.ru/books?id=0vXTBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.whocc.no/atc_ddd_index/?code=C02LG03

Picodralazine is a peripheral vasodilator, sympatholytic agent exerting antihypertensive properties.

Approval Year

Patents

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:10:49 GMT 2025` Edited by `admin` on `Mon Mar 31 18:10:49 GMT 2025`
Record UNII	O9D004V63I
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PICODRALAZINE

Official Name

English

1-HYDRAZINO-4-(4-PYRIDLMETHYL)PHTHALAZENE

Preferred Name

English

PICODRALAZINE [MART.]

Common Name

English

picodralazine [INN]

Common Name

English

Classification Tree Code System Code

WHO-ATC

C02LG73

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

WHO-VATC

QC02LG73

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

WHO-VATC

QC02LG03

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

NCI_THESAURUS

C29707

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

WHO-ATC

C02LG03

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

Code System Code Type Description

ECHA (EC/EINECS)

241-684-2

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

INN

2405

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

FDA UNII

O9D004V63I

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

SMS_ID

100000081939

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

DRUG CENTRAL

4689

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

ChEMBL

CHEMBL1968696

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

EVMPD

SUB09815MIG

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

EPA CompTox

DTXSID0048715

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

PUBCHEM

71890

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

NCI_THESAURUS

C66382

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

CAS

17692-43-2

Created by admin on Mon Mar 31 18:10:49 GMT 2025 , Edited by admin on Mon Mar 31 18:10:49 GMT 2025

PRIMARY

Related Record Type Details


					O9D004V63I

ACTIVE MOIETY